Fusidic acid, Betamethasone

Fucibet 20 MG/G + 1 MG/G Crema

20 mg + 1,214 mg cremaSpainMarketedAuthorised 28 Aug 2025

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Fusidic acid, Betamethasone

Fucibet 20 MG/G + 1 MG/G Crema

20 mg + 1,214 mg cremaSpainMarketedAuthorised 28 Aug 2025

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Defuzin-BetaV CreamSingapore · 0.10g/100g + 2g/100g · cream · Apex Pharma Marketing Pte. LTD.

Fobancort OintmentSingapore · 0.064% w/w + 2% w/w · ointment · Zuellig Pharma Pte. LTD.

ácido fusídico + valerato de betametasonaBrazil · Multilab Industria e Comercio de Produtos Farmaceuticos Ltda

Verutex BBrazil · Leo Pharma Ltda

Ácido Fusídico+Valerato de BetametasonaBrazil · Germed Farmaceutica Ltda

AnyNew Zealand · Crm 0.1% with sodium fusidate (fusidic acid) 2%

FucicortNew Zealand · Crm 0.1% with sodium fusidate (fusidic acid) 2%

Packs

Pack	Code	Status
FUCIBET 20 MG/G + 1 MG/G CREMA, 1 tubo de 30 g	768322

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substances: Fusidic acid, Betamethasone
Strength: 20 mg + 1,214 mg
Dosage form: crema
Route: uso cutáneo
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 28 Aug 2025
Registration: 20000217IP
Marketing authorisation holder: Leo Pharma A/S
Procedure: National, MRP or DCP
Supply: Medicamento Sujeto A Prescripción Médica

Fusicutanbeta 20 MG/G + 1 MG/G CremaFusidic acid + Betamethasone · 20.40 mg + 1.214 mg · cremaSpain

Befudin 20 MG/G + 1 MG/G CremaFusidic acid + Betamethasone · 20 mg/g + 1,214 mg/g · cremaSpain

Cortifusin 20 MG/G + 1 MG/G CremaFusidic acid + Betamethasone · 20 mg/g + 1,214 mg/g · cremaSpain

Fucibet 20 MG/G + 1 MG/G CremaFusidic acid + Betamethasone · 2 g + 0,1 g · cremaSpain

Fucibet 20 MG/G + 1 MG/G CremaFusidic acid + Betamethasone · 20 mg + 1 mg · cremaSpainWithdrawn

FUCIBET 20mg/g+1mg/g cremaFusidic acid + Betamethasone · 20 mg + 1 mg · cremaSpainWithdrawn